Clinical trial
A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the…
NCT00232414 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00232414 |
|---|---|
| Title | A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder |
| Official title | A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar I Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine |
| Enrollment | 30 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: